Page last updated: 2024-10-25

deferoxamine and Leukemia, Lymphoid

deferoxamine has been researched along with Leukemia, Lymphoid in 3 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Leukemia, Lymphoid: Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts.

Research Excerpts

ExcerptRelevanceReference
"Deferoxamine is a hydroxylamine which binds ferric ions to form a highly stable complex."1.27Inhibition of proliferation of human leukaemic cell populations by deferoxamine. ( Foa, P; Lombardi, L; Maiolo, AT; Polli, EE; Villa, L, 1986)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hunt, FC1
Foa, P1
Maiolo, AT1
Lombardi, L1
Villa, L1
Polli, EE1
Estrov, Z1
Tawa, A1
Wang, XH1
Dubé, ID1
Sulh, H1
Cohen, A1
Gelfand, EW1
Freedman, MH1

Other Studies

3 other studies available for deferoxamine and Leukemia, Lymphoid

ArticleYear
Chelator-induced enhancement of 67Ga tumour imaging: comparison of desferrioxamine with N,N'-ethylene-bis[2-hydroxy-5-carboxyphenylglycine].
    International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1988, Volume: 15, Issue:6

    Topics: Animals; Chelating Agents; Citrates; Citric Acid; Deferoxamine; Ethylenediamines; Leukemia, Lymphoid

1988
Inhibition of proliferation of human leukaemic cell populations by deferoxamine.
    Scandinavian journal of haematology, 1986, Volume: 36, Issue:1

    Topics: Cell Division; Cell Line; Deferoxamine; DNA; Humans; Interphase; Leukemia; Leukemia, Lymphoid; Leuke

1986
In vitro and in vivo effects of deferoxamine in neonatal acute leukemia.
    Blood, 1987, Volume: 69, Issue:3

    Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Cel

1987